| 
CD4 T-Cell
Count / Percent
Do
Sex and CD4
Count Predict
Risk of Nevirapine (Viramune) Side Effects? -
2/01/08
Impact
of Episodic CD4-guided
Treatment Interruption on Quality of Life -
1/29/08
Appearance
of HIV-related Kaposi's Sarcoma (KS) in Older HIV Patients with a High CD4
Count and a Low Viral Load -
10/02/07
Switching
to Nevirapine (Viramune) Appears Generally Safe for Patients with High CD4
Cell Counts -
10/02/07
Starting
HAART with a Higher CD4
Cell Count Improves
Immune Recovery and Reduces the Risk of Disease Progression or Death - 8/31/07
Protease
Inhibitor and PI-sparing Regimens Provide Similar Levels of Long-term Immune Reconstitution
in Patients with
Low CD4 Cell Counts - 8/17/07
Methamphetamine
Use Associated with Lower
CD4 Cell Counts in
People with HIV - 7/25/07
3
Months of HAART During Primary HIV Infection Is Associated with Slower CD4
Cell Decline
- 7/03/07
Most
Patients Starting with CD4 Cell Counts of at Least 350 Can Achieve 800
or More after 7 Years of HAART
- 6/22/07
HIV
Viral Load Predicts Disease Progression Better than CD4 Cell Count
- 4/13/07
Women
with Subtype D HIV-1 are More Likely to Die and Experience Faster CD4 Cell
Decline - 3/16/07
Risk
of TB-associated Immune Reconstitution Disease Is High in South African Patients
Initiating Antiretroviral Therapy with Low Baseline CD4 Cell Counts
- 3/16/07
Absolute
CD4 Cell Count and CD4 Percentage Independently Predict HIV Disease Progression 2/13/07
Trends
over Time in CD4 Cell Count and HIV Viral Load after Seroconversion
2/13/07
SMART
Data Confirm Risk of CD4-guided Treatment Interruptions
12/08/06
Increased
Clinical Events in Patients with Virological Suppression but Persistent CD4
Count below 200 Cells/mm3
9/29/06
When
Does CD4 Cell Count Plateau? Evidence from Patients Treated with Lopinavir/ritonavir
for up to 7 Years
9/29/06
HIV
Persists in Aged Memory CD4 Cells during 8 Years of Effective HAART
9/29/06
Four-year
Analysis of Tenofovir/Didanosine Combination Therapy Effects on Lymphocytes, CD4
and Viral Load - 8/18/06
Suboptimal
CD4 Increases in HIV-infected Patients Receiving Didanosine plus Tenofovir
- 4/14/06
Daily
Use of Recombinant Human Growth Hormone Increases HIV-specific T cell Responses
and Interferon-producing CD8 T Cell Responses in Patients on Antiretroviral Therapy
- 3/07/06
Predictors
for Changes in CD4 Cell Count 7 Years after Starting HAART - 3/07/06
CD4
Cell Count Increases in Patients with Sustained Virologic Suppression up to
5 Years - 3/07/06
No
Clinical Benefit from a 4-drug (2 PIs) Regimen in Patients with Low CD4 Count
and High Viral Load - 1/17//06
CD4+
Cell Count, Viral Load and HAART Independently Predict Body Composition Changes
in HIV Positive Adults - 11/30/05
CD4
Cell Count in the Lungs Predict Survival in Asymptomatic HIV Infection
- 10/31/05
Prognostic
Factors in HIV-related Diffuse Large-Cell Lymphoma: Before Versus after HAART
- 10/24/05
Treatment
Interruption as a Viable Option in Patients with Lowest CD4 Cell Count
>250 Cells - 10/21/05
| 
